a SERM approved by the U.S. Food and Drug Administration (FDA) to: reduce the risk of hormone-receptor-positive breast cancer in postmenopausal women who haven’t been diagnosed but are at higher-than-average risk for disease.
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your review *
Save my name, email, and website in this browser for the next time I comment.